278 related articles for article (PubMed ID: 18046482)
1. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Photochem Photobiol Sci; 2007 Dec; 6(12):1275-83. PubMed ID: 18046482
[TBL] [Abstract][Full Text] [Related]
2. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Lasers Surg Med; 2011 Sep; 43(7):651-62. PubMed ID: 22057493
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy.
Bhuvaneswari R; Thong PS; Gan YY; Soo KC; Olivo M
J Biomed Opt; 2010; 15(1):011114. PubMed ID: 20210440
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.
Bhuvaneswari R; Gan YY; Lucky SS; Chin WW; Ali SM; Soo KC; Olivo M
Mol Cancer; 2008 Jun; 7():56. PubMed ID: 18549507
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
8. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
Yee KK; Soo KC; Olivo M
Int J Mol Med; 2005 Dec; 16(6):993-1002. PubMed ID: 16273277
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer.
Peng CL; Lin HC; Chiang WL; Shih YH; Chiang PF; Luo TY; Cheng CC; Shieh MJ
Photodiagnosis Photodyn Ther; 2018 Sep; 23():111-118. PubMed ID: 29894822
[TBL] [Abstract][Full Text] [Related]
11. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.
Solban N; Selbo PK; Sinha AK; Chang SK; Hasan T
Cancer Res; 2006 Jun; 66(11):5633-40. PubMed ID: 16740700
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
Chen B; Zupkó I; de Witte PA
Int J Oncol; 2001 Apr; 18(4):737-42. PubMed ID: 11251168
[TBL] [Abstract][Full Text] [Related]
14. Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model.
Ferrario A; Gomer CJ
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):251-9. PubMed ID: 16566722
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
Du HY; Bay BH; Olivo M
Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
[TBL] [Abstract][Full Text] [Related]
16. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
Chin W; Lau W; Cheng C; Olivo M
Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
[TBL] [Abstract][Full Text] [Related]
19. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hexamethylhypericin and tetrabromohypericin to hypericin for their in vivo efficacy as PDT tools.
Delaey E; Zupko I; Chen B; Derycke A; van Laar F; De Vos D; De Witte P
Int J Oncol; 2003 Aug; 23(2):519-24. PubMed ID: 12851704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
